| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2009 | WO2009023355A3 Compositions and methods for reducing the toxicity of certain toxins |
| 07/09/2009 | WO2009017755A3 Cb1 antagonists and inverse agonists |
| 07/09/2009 | WO2009012096A3 Improved therapeutic methods and compositions comprising chroman ring compounds |
| 07/09/2009 | WO2009008991A3 Dna-pkcs modulates energy regulation and brain function |
| 07/09/2009 | WO2008151833A3 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds |
| 07/09/2009 | WO2008148747A3 Pdz domain modulators |
| 07/09/2009 | WO2008147864A3 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| 07/09/2009 | WO2008147797A3 Ion channel modulators and methods of use |
| 07/09/2009 | WO2008147474A8 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | WO2008136976A3 Compounds for treating proliferative disorders |
| 07/09/2009 | WO2008132234A4 Rna antagonist compounds for the modulation of beta-catenin |
| 07/09/2009 | WO2008130368A3 Transcription factor modulating compounds and methods of use thereof |
| 07/09/2009 | WO2008109180A3 Metalloprotease inhibitors containing a heterocyclic moiety |
| 07/09/2009 | WO2008083192A8 Methods and formulations for improved bioavailability of antiprogestins |
| 07/09/2009 | WO2008058697A8 Sorption medium |
| 07/09/2009 | WO2008054431A3 Anti-hyperproliferative therapies targeting hdgf |
| 07/09/2009 | WO2008041140A8 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | WO2008039087A8 Indoline derivatives and uses thereof |
| 07/09/2009 | US20090178153 G protein coupled receptors and uses thereof |
| 07/09/2009 | US20090178148 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/09/2009 | US20090176987 Crystal form of quinoline compound and process for its production |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176969 Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use |
| 07/09/2009 | US20090176890 Edible plant extract based insecticidal composition |
| 07/09/2009 | US20090176889 Compounds for the treatment of metabolic disorders |
| 07/09/2009 | US20090176888 Composition comprising phytosphingosine or derivative thereof |
| 07/09/2009 | US20090176887 Biocidal Compositions and Methods |
| 07/09/2009 | US20090176886 Polymorphic Forms of Oseltamivir Phosphate |
| 07/09/2009 | US20090176885 Compounds for the treatment of metabolic disorders |
| 07/09/2009 | US20090176884 Pharmaceutical suspension composition |
| 07/09/2009 | US20090176883 TRPA1 Antagonists |
| 07/09/2009 | US20090176882 Gastric retentive gabapentin dosage forms and methods for using same |
| 07/09/2009 | US20090176881 Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176879 Fatty acid desaturases from primula |
| 07/09/2009 | US20090176878 Genetic polymorphisms and substance dependence |
| 07/09/2009 | US20090176877 Oseltamivir phoshate granule and preparation method thereof |
| 07/09/2009 | US20090176876 Compositions, kits and regimens for the treatment of skin, especially decolletage |
| 07/09/2009 | US20090176875 Method for manufacturing metal nano particle solution |
| 07/09/2009 | US20090176874 Tnp-470 polymer conjugates and use thereof |
| 07/09/2009 | US20090176873 Novel use of organic compounds |
| 07/09/2009 | US20090176872 Carotenoid Composition and Method for Protecting Skin |
| 07/09/2009 | US20090176871 Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones |
| 07/09/2009 | US20090176870 Tgf-beta modulators and methods for using the same |
| 07/09/2009 | US20090176869 Halogenated Rhodamine Derivatives and Applications Thereof |
| 07/09/2009 | US20090176867 for congenital muscular dystrophy or myopathy resulting from mutations in any of the collagen VI genes selected from the group consisting of Col6A1, Col6A2, and Col6A3; administered orally; normalizes the pathological changes at the ultrastructural level in mitochondria of muscle tissue |
| 07/09/2009 | US20090176866 Complexes having adjuvant activity |
| 07/09/2009 | US20090176865 Sulfamide derivative useful for the treatment of epilepsy |
| 07/09/2009 | US20090176864 Methods For Improving Hepatic and Immune Function In An Animal |
| 07/09/2009 | US20090176863 Thiophene derivative ppar modulators |
| 07/09/2009 | US20090176862 Methods for treating chemotherapy and radiation therapy side effects |
| 07/09/2009 | US20090176861 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176860 Zofenopril calcium |
| 07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176858 Hcv protease inhibitors and uses thereof |
| 07/09/2009 | US20090176857 Use of Organic Compounds |
| 07/09/2009 | US20090176856 Muscarinic receptor antagonists |
| 07/09/2009 | US20090176855 Treatment of bipolar disorders and associated symptoms |
| 07/09/2009 | US20090176854 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176852 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 07/09/2009 | US20090176851 Use of Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 |
| 07/09/2009 | US20090176850 Novel 2-Amino-Imidazole-4-One Compounds And Their Use In The Manufacture Of A Medicament To Be Used In The Treatment Of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration And Dementia |
| 07/09/2009 | US20090176849 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives |
| 07/09/2009 | US20090176848 Fortifier |
| 07/09/2009 | US20090176847 Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof |
| 07/09/2009 | US20090176846 N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1, 3-thiazol-4-yl) phenoxy] pentoxy} benzamidine 2 methanesulfonic acid salt |
| 07/09/2009 | US20090176845 adrenergic receptor agonists such as (8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propyl-pyridin-4-ylmethyl-amine, used as analgesics, decongestants, antidepressants and anxiolytic agents or for the treatment of vision defects, neurodegenerative diseases, diarrhea, attention deficit disorder, psychoses |
| 07/09/2009 | US20090176843 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/09/2009 | US20090176842 Substituted arylsulfonamides as antiviral agents |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 07/09/2009 | US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/09/2009 | US20090176839 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/09/2009 | US20090176838 Cyclourea Compounds as Calcium Channel Blockers |
| 07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
| 07/09/2009 | US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins |
| 07/09/2009 | US20090176835 Pharmaceutical composition for suppression of the expression of atp citrate lyase and use thereof |
| 07/09/2009 | US20090176834 Sublingual fentanyl spray |
| 07/09/2009 | US20090176833 biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; pulmonary disorders |
| 07/09/2009 | US20090176832 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/09/2009 | US20090176831 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System |
| 07/09/2009 | US20090176830 Tartrate salt of isofagomine and methods of use |
| 07/09/2009 | US20090176829 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/09/2009 | US20090176828 treating pain with minimal cardiovascular and/or sedatory activity side effects;hypertension, depression, glaucoma, elevated intraocular pressure, ischemic neuropathies, optic neuropathy, diabetic retinopathy, stroke, withdrawal symptoms, obsessive compulsive disorder, obesity, diarrhea, nasal congestion |
| 07/09/2009 | US20090176827 Maleate salts of (e)-n--4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 07/09/2009 | US20090176826 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/09/2009 | US20090176825 Prolyl hydroxylase inhibitors |
| 07/09/2009 | US20090176824 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field |
| 07/09/2009 | US20090176823 Secondary Amines as Renin Inhibitors |
| 07/09/2009 | US20090176822 Pyrrolidine inhibitors of iap |
| 07/09/2009 | US20090176821 Amide and Carbamate Derivatives of Alkyl Substituted N-[4-(4-Amino-1H-Imidazo[4,5-C] Quinolin-1-YL)Butyl]Methanesulfonamides and Methods |
| 07/09/2009 | US20090176820 Polymorphic forms and process |
| 07/09/2009 | US20090176819 39-Desmethoxy-39-Methyl Derivatives of Rapamycin |
| 07/09/2009 | US20090176818 Antitussive Agent |
| 07/09/2009 | US20090176817 Method of Treatment of Diarrhea-Predominant Irritable Bowel Syndrome in a Subject |
| 07/09/2009 | US20090176816 Drug composition for treating 2 type diabetes and diabetic chronicity complications |
| 07/09/2009 | US20090176815 Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor Activity |